CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Insight Molecular Diagnostics Inc.

IMDX
$124MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for IMDX. That does not mean none is planned.

Get an email about IMDX's next catalysts

Track Insight Molecular Diagnostics (IMDX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 2 past

No catalysts found.

How IMDX's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQIn Vitro & In Vivo Diagnostic SubstancesπŸ‡ΊπŸ‡ΈNorth AmericaNASHVILLE

Frequently asked questions

What is in Insight Molecular Diagnostics Inc.'s drug pipeline?β†’

CatalystAlert tracks 8 drug candidates in Insight Molecular Diagnostics Inc.'s (IMDX) pipeline across Phase 3, Phase 2. Its lead program is 99mTc-MIP-1404 Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Insight Molecular Diagnostics Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Insight Molecular Diagnostics Inc. (IMDX) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track IMDX biotech catalysts?β†’

Add IMDX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Insight Molecular Diagnostics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply